Standout Papers

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants 2023 2026 2024146
  1. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (2023)
    Simon B. Drysdale, Katrina Cathie et al. New England Journal of Medicine

Immediate Impact

16 standout
Sub-graph 1 of 8

Citing Papers

Therapeutic advances in rheumatoid arthritis
2024 Standout
Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine
2024 Standout
2 intermediate papers

Works of Karine Mari being referenced

Technology Applications: Use of Digital Health Technology to Enable Drug Development
2018
Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis
2016

Author Peers

Author Last Decade Papers Cites
Karine Mari 212 91 27 82 16 363
R. L. Muldoon 172 47 10 79 18 326
Douglas Rg 166 49 7 39 24 406
Yoshiki Chiba 281 78 5 21 30 386
P. H. Phipps 166 27 5 58 14 346
Jérôme Jacques 209 28 18 19 17 406
P. A. Phillips 97 100 4 101 22 372
Kristin MacDonald 251 39 7 27 9 367
M. A. Chernesky 181 86 24 18 15 404
B. Hoorn 224 63 23 31 14 398
A. A. Ferris 235 33 7 23 25 340

All Works

Loading papers...

Rankless by CCL
2026